Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Englund

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Frontiers in Cardiovascular Medicine|June 30, 2026
Single-catheter radiofrequency pulmonary vein isolation for atrial fibrillation: a comparative evaluationAlessio Falasca Zamponi, Fariborz Tabrizi, Anders Englund, et al.
Clinical Drug Investigation|June 10, 2010
Effects of AZD0837, a novel direct thrombin inhibitor, on the electrophysiological properties of the human heart: a randomized, double-blind, parallel-group, placebo-controlled studyHåkan Walfridsson, Birgitta Johansson, Anders Englund, et al.
Heart (British Cardiac Society)|August 28, 2016
Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trialJens Cosedis Nielsen, Arne Johannessen, Pekka Raatikainen, et al.
The New England Journal of Medicine|October 26, 2012
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillationJens Cosedis Nielsen, Arne Johannessen, Pekka Raatikainen, et al.
Journal of Cardiovascular Pharmacology|July 1, 2010
A randomized invasive cardiac electrophysiology study of the combined ion channel blocker AZD1305 in patients after catheter ablation of atrial flutterLauri Toivonen, Pekka Raatikainen, Håkan Walfridsson, et al.
Diabetes|March 30, 2026
LEAP2 Reduces Ad Libitum Food Intake and Attenuates Postprandial Glucose Excursions in Men With ObesityAnders Englund, Andreas H Lange, Christoffer A Hagemann, et al.
International Journal of Cardiology|July 13, 2015
Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trialM J Pekka Raatikainen, Antti Hakalahti, Paavo Uusimaa, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 25, 2016
Higher burden of supraventricular ectopic complexes early after catheter ablation for atrial fibrillation is associated with increased risk of recurrent atrial fibrillationChristina Alhede, Arne Johannessen, Ulrik Dixen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 25, 2014
The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudyMattias Aronsson, Håkan Walfridsson, Magnus Janzon, et al.
International Journal of Cardiology|May 17, 2017
Antiarrhythmic medication is superior to catheter ablation in suppressing supraventricular ectopic complexes in patients with atrial fibrillationChristina Alhede, Trine K Lauridsen, Arne Johannessen, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Frontiers in Cardiovascular Medicine|June 30, 2026
Single-catheter radiofrequency pulmonary vein isolation for atrial fibrillation: a comparative evaluationAlessio Falasca Zamponi, Fariborz Tabrizi, Anders Englund, et al.
Clinical Drug Investigation|June 10, 2010
Effects of AZD0837, a novel direct thrombin inhibitor, on the electrophysiological properties of the human heart: a randomized, double-blind, parallel-group, placebo-controlled studyHåkan Walfridsson, Birgitta Johansson, Anders Englund, et al.
Heart (British Cardiac Society)|August 28, 2016
Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trialJens Cosedis Nielsen, Arne Johannessen, Pekka Raatikainen, et al.
The New England Journal of Medicine|October 26, 2012
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillationJens Cosedis Nielsen, Arne Johannessen, Pekka Raatikainen, et al.
Journal of Cardiovascular Pharmacology|July 1, 2010
A randomized invasive cardiac electrophysiology study of the combined ion channel blocker AZD1305 in patients after catheter ablation of atrial flutterLauri Toivonen, Pekka Raatikainen, Håkan Walfridsson, et al.
Diabetes|March 30, 2026
LEAP2 Reduces Ad Libitum Food Intake and Attenuates Postprandial Glucose Excursions in Men With ObesityAnders Englund, Andreas H Lange, Christoffer A Hagemann, et al.
International Journal of Cardiology|July 13, 2015
Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trialM J Pekka Raatikainen, Antti Hakalahti, Paavo Uusimaa, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 25, 2016
Higher burden of supraventricular ectopic complexes early after catheter ablation for atrial fibrillation is associated with increased risk of recurrent atrial fibrillationChristina Alhede, Arne Johannessen, Ulrik Dixen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 25, 2014
The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudyMattias Aronsson, Håkan Walfridsson, Magnus Janzon, et al.
International Journal of Cardiology|May 17, 2017
Antiarrhythmic medication is superior to catheter ablation in suppressing supraventricular ectopic complexes in patients with atrial fibrillationChristina Alhede, Trine K Lauridsen, Arne Johannessen, et al.
Pageof 5